Literature DB >> 2942317

Defective autologous mixed lymphocyte reactivity in multiple sclerosis.

R L Hirsch.   

Abstract

T cells from patients with multiple sclerosis (MS) and normal controls were assessed for their ability to respond in the autologous mixed lymphocyte reaction (AMLR). Cells from stable MS patients demonstrated a significant defect in their proliferative response to non-T cells in comparison to normal controls. Despite the defective AMLR response, T cells from MS patients reacted as well as T cells from normal controls to allogeneic stimuli. Furthermore, MS non-T-cells were fully capable of stimulating allogeneic MLR responses by normal and MS T cells. Since the T4+ cell is the major subpopulation which proliferates in the AMLR, these studies suggest a functional defect in a subpopulation of T4+ cells in MS patients. Since the AMLR may represent an important mechanism by which immune responses are regulated, a defect in the ability of MS T cells to respond to autologous cells could account for several of the autoimmune features of the disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2942317      PMCID: PMC1542138     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  35 in total

1.  NK and T cell subsets regulate antibody production by human in vivo antigen-induced lymphoblastoid B cells.

Authors:  J A Brieva; S Targan; R H Stevens
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

2.  The human autologous mixed lymphocyte reaction. III. Immune circuits.

Authors:  J S Smolen; T M Chused; E A Novotny; A D Steinberg
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

3.  Functional analysis of human T cell subsets defined by monoclonal antibodies. V. Suppressor cells within the activated OKT4+ population belong to a distinct subset.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; H H Shen; M A Talle; G Goldstein; L Chess
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

4.  Homeostasis of the antibody response: immunoregulation by NK cells.

Authors:  L V Abruzzo; D A Rowley
Journal:  Science       Date:  1983-11-11       Impact factor: 47.728

5.  T-lymphocyte subsets in cerebrospinal fluid in multiple sclerosis.

Authors:  H S Panitch; G S Francis
Journal:  N Engl J Med       Date:  1982-08-26       Impact factor: 91.245

6.  Lymphocyte populations in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis and optic neuritis.

Authors:  M Sandberg-Wollheim
Journal:  Scand J Immunol       Date:  1983-06       Impact factor: 3.487

7.  Cerebrospinal fluid lymphocytes from patients with multiple sclerosis and aseptic meningo-encephalitis respond in mixed lymphocyte culture.

Authors:  S Kam-Hansen; R Andersson; H Link
Journal:  J Neuroimmunol       Date:  1983-08       Impact factor: 3.478

8.  A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.

Authors:  T Sakane; H Kotani; S Takada; Y Murakawa; Y Ueda
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

9.  Autologous mixed lymphocyte reaction in man. V. Functionally and phenotypically distinct human T-cell subpopulations respond to non-T and activated T cells in AMLR.

Authors:  N K Damle; S Gupta
Journal:  Scand J Immunol       Date:  1982-07       Impact factor: 3.487

10.  Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production.

Authors:  R L Hirsch; F Mokhtarian; D E Griffin; B R Brooks; J Hess; R T Johnson
Journal:  Clin Immunol Immunopathol       Date:  1981-12
View more
  5 in total

1.  Impairment of autologous mixed lymphocyte reaction in the spleen and peripheral blood lymphocytes of patients with idiopathic portal hypertension.

Authors:  H Yamaue; H Tanimura; M Iwahashi; T Tsunoda; M Tani; M Tamai; M Inoue
Journal:  Gastroenterol Jpn       Date:  1990-04

2.  Multiple sclerosis: II. Effects of prothymosin alpha on the autologous and allogeneic MLR in patients with multiple sclerosis.

Authors:  G J Reclos; C N Baxevanis; C Sfagos; C Papageorgiou; G C Tsokos; M Papamichail
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

3.  Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.

Authors:  R Benvenuto; M Paroli; C Buttinelli; A Franco; V Barnaba; C Fieschi; F Balsano
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

4.  Human CD4(+) effector T lymphocytes generated upon TCR engagement with self-peptides respond defectively to IL-7 in their transition to memory cells.

Authors:  Gabriela González-Pérez; Norma C Segovia; Amaranta Rivas-Carvalho; Diana P Reyes; Honorio Torres-Aguilar; Sergio R Aguilar-Ruiz; Claudine Irles; Gloria Soldevila; Carmen Sánchez-Torres
Journal:  Cell Mol Immunol       Date:  2013-03-04       Impact factor: 11.530

5.  Multiple sclerosis: I. Monocyte stimulatory defect in mixed lymphocyte reaction associated with clinical disease activity.

Authors:  C N Baxevanis; G J Reclos; C Sfagos; E Doufexis; C Papageorgiou; M Papamichail
Journal:  Clin Exp Immunol       Date:  1987-02       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.